Male circumcision and prevention of HIV and sexually transmitted infections.

Ronald H Gray, Maria J Wawer, Chelsea B Polis, Godfrey Kigozi, David Serwadda
Author Information
  1. Ronald H Gray: Johns Hopkins University, Bloomberg School of Public Health, E4132, 615 North Wolfe Street, Baltimore, MD 21215, USA. rgray@jhsph.edu

Abstract

Three randomized trials in Africa have shown that adult male circumcision reduces HIV acquisition in men by approximately 60%. It is biologically plausible that circumcision reduces HIV risk in men because the inner mucosa of the foreskin is lightly keratinized and has a high density of dendritic cells and other HIV target cells, making it vulnerable to HIV infection. Also, the foreskin is retracted over the shaft during intercourse, exposing the inner mucosa to vaginal secretions; the prepuce is vulnerable to trauma during coitus, providing a portal for HIV entry. In addition, circumcision reduces the rate of reported genital ulceration, which is a cofactor for HIV acquisition. Male circumcision may also reduce some other sexually transmitted infections in men and their female partners. For these reasons, male circumcision should be promoted as a component of HIV prevention strategies.

References

  1. Scand J Urol Nephrol Suppl. 2000;(205):189-93 [PMID: 11144896]
  2. J Infect Dis. 1999 Aug;180(2):330-6 [PMID: 10395846]
  3. J Acquir Immune Defic Syndr. 2005 May 1;39(1):82-9 [PMID: 15851918]
  4. AIDS. 2007 Apr 23;21(7):845-50 [PMID: 17415039]
  5. AIDS. 2000 Sep 8;14(13):1917-20 [PMID: 10997395]
  6. BMJ. 2000 Jun 10;320(7249):1592-4 [PMID: 10845974]
  7. Lancet. 2007 Feb 24;369(9562):657-66 [PMID: 17321311]
  8. Sex Transm Infect. 2006 Apr;82(2):101-9; discussion 110 [PMID: 16581731]
  9. Sex Transm Dis. 2001 Oct;28(10):608-12 [PMID: 11689759]
  10. J Infect Dis. 2005 Feb 15;191(4):546-53 [PMID: 15655778]
  11. AIDS. 2000 Oct 20;14(15):2361-70 [PMID: 11089625]
  12. Int J Epidemiol. 1990 Sep;19(3):693-7 [PMID: 2262266]
  13. Sex Transm Infect. 1998 Oct;74(5):368-73 [PMID: 10195035]
  14. Lancet. 2004 Mar 27;363(9414):1039-40 [PMID: 15051285]
  15. Sex Transm Dis. 2001 Oct;28(10):579-97 [PMID: 11689757]
  16. AIDS. 2006 Jul 13;20(11):1491-5 [PMID: 16847403]
  17. AIDS. 2000 Oct 20;14(15):2371-81 [PMID: 11089626]
  18. N Engl J Med. 2002 Apr 11;346(15):1105-12 [PMID: 11948269]
  19. Immunol Cell Biol. 2000 Dec;78(6):586-95 [PMID: 11114968]
  20. AIDS. 1994 Feb;8(2):153-60 [PMID: 8043224]
  21. PLoS Med. 2005 Nov;2(11):e298 [PMID: 16231970]
  22. J Acquir Immune Defic Syndr. 2006 Sep;43(1):69-77 [PMID: 16878046]
  23. Soc Sci Med. 2004 May;58(9):1751-6 [PMID: 14990375]
  24. PLoS Med. 2008 Jun 3;5(6):e116 [PMID: 18532873]
  25. Sex Transm Dis. 2001 Jun;28(6):330-5 [PMID: 11403190]
  26. Sex Transm Infect. 2000 Dec;76(6):474-9 [PMID: 11221132]
  27. AIDS. 1994 Jan;8(1):93-9 [PMID: 8011242]
  28. Sex Transm Dis. 2000 Aug;27(7):417-23 [PMID: 10949433]
  29. Am J Pathol. 2002 Sep;161(3):867-73 [PMID: 12213715]
  30. Cancer. 1994 Sep 15;74(6):1762-7 [PMID: 8082079]
  31. BJU Int. 2008 Jan;101(1):65-70 [PMID: 18086100]
  32. Lancet Infect Dis. 2005 Mar;5(3):165-73 [PMID: 15766651]
  33. Pediatrics. 2006 Nov;118(5):1971-7 [PMID: 17079568]
  34. AIDS. 2001 Jun 15;15(9):1188-9 [PMID: 11416727]
  35. AIDS. 2005 Dec 2;19(18):2181-2 [PMID: 16284475]
  36. AIDS. 1999 Feb 25;13(3):399-405 [PMID: 10199231]
  37. Sex Transm Dis. 2004 Oct;31(10):601-7 [PMID: 15388997]
  38. AIDS. 1989 Jun;3(6):373-7 [PMID: 2502151]
  39. AIDS. 2004 Dec 3;18(18):2428-30 [PMID: 15622320]
  40. Lancet. 2007 Feb 24;369(9562):643-56 [PMID: 17321310]
  41. J Infect Dis. 1993 Dec;168(6):1404-8 [PMID: 8245525]
  42. Lancet. 2006 Aug 5;368(9534):489-504 [PMID: 16890836]
  43. J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):66-70 [PMID: 17019365]
  44. AIDS Behav. 2007 May;11(3):341-55 [PMID: 17053855]